Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current pathophysiological aspects of systemic sclerosis].

T Krieg1, N Hunzelmann

  • 1Klinik und Poliklinik für Dermatologie und Venerologie, Universität zu Köln, Joseph-Stelzmann-Strasse 9, 50924, Köln, Germany. nico.hunzelmann@uni-koeln.de

Zeitschrift Fur Rheumatologie
|June 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis.

Rheumatology (Oxford, England)·2024
Same author

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

[Systemic sclerosis].

Dermatologie (Heidelberg, Germany)·2024
Same author

Acute regional changes in myocardial strain may predict ventricular remodelling after myocardial infarction in a large animal model.

Scientific reports·2021
Same author

[How I treat calcinosis cutis in the context of collagenosis…].

Zeitschrift fur Rheumatologie·2021
Same author

[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany].

Zeitschrift fur Rheumatologie·2020
Same journal

Methodological concerns and data discrepancies in the indirect treatment comparison of belimumab and anifrolumab.

Zeitschrift fur Rheumatologie·2026
Same journal

Evaluating the comparative efficacy of belimumab vs. anifrolumab in systemic lupus erythematosus: a response.

Zeitschrift fur Rheumatologie·2026
Same journal

[Update: DMARDs for MGUS].

Zeitschrift fur Rheumatologie·2026
Same journal

[A potpourri of diagnoses-Unusual manifestations of a chronic inflammatory bowel disease : Case report].

Zeitschrift fur Rheumatologie·2026
Same journal

[Not measurable but immeasurably important : Fever-The leading symptom of ancient medical theory].

Zeitschrift fur Rheumatologie·2026
Same journal

[Survey of care situation for patients with systemic lupus erythematosus and systemic sclerosis with pulmonary involvement in Rhineland-Palatinate and Saarland].

Zeitschrift fur Rheumatologie·2026
See all related articles

Systemic scleroderma involves chronic inflammation and connective tissue buildup, impacting organs and skin. Recent advances focus on vascular system interactions and pathophysiology for new therapeutic strategies.

Area of Science:

  • Rheumatology
  • Immunology
  • Pathophysiology

Context:

  • Systemic scleroderma is a chronic autoimmune disease.
  • Characterized by inflammation and fibrosis in multiple organs.
  • Etiology remains largely unknown, highlighting a need for research.

Purpose:

  • To review recent advancements in understanding systemic scleroderma pathophysiology.
  • To highlight the role of vascular involvement and connective tissue interaction.
  • To inform the development of novel therapeutic concepts.

Summary:

  • Systemic scleroderma features chronic inflammation and excessive connective tissue deposition.
  • Vascular system compromise and subsequent fibrosis cause organ atrophy and dysfunction.
  • Current research emphasizes the interplay between vascular and connective tissues.

Related Experiment Videos

Impact:

  • Provides updated insights into systemic scleroderma pathogenesis.
  • Identifies key areas for future research and therapeutic development.
  • Enhances understanding of disease mechanisms for improved patient outcomes.